Agile Therapeutics up after Maxim raises rating to "buy"

Agile Therapeutics

26/07/2022 18:52

** Shares of Agile Therapeutics Inc  AGRX.O  up 6.2% at 53
cents after Maxim raises its rating on the drugmaker to "buy"
from "hold" 
    ** Brokerage says AGRX's recent equity offering and its
efforts to refine its commercial efforts with its Twirla
contraceptive patch has addressed the brokerage's concerns over
a possible cash crunch
    ** Says the company can shift focus on marketing of Twirla,
which combined with the recent overturning of the Roe V. Wade
ruling, should help AGRX shares rebound
    ** Retail investors in early July flocked to small biotech
firms such as AGRX that make women contraceptives after the U.S.
 Supreme Court overturned the ruling that recognized the
constitutional right to abortion  urn:newsml:reuters.com:*:nL4N2YI2N3
    ** Including session's gains, stock down nearly ~97% YTD

 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))